Notably, our integrated profiling unveiled that METTL3-m6A played a direct role in regulating key extracellular signaling pathways involved in epithelial mesenchymal transition (EMT), tumor growth or metastasis, including the SMAD protein signaling transduction and negative regulation of MAPK pathways [57–60]. This evidence concerns the gene METTL3 and neoplasm.